Find public sector tenders

The DHSC - UK National Screening Committee is issuing this Prior Information Notice to seek information and feedback from the market to gain better understanding of the intelligence, costing and appetite for this project.

The DHSC - UK National Screening Committee is issuing this Prior Information Notice to seek information and feedback from the market to gain better understanding of the intelligence, costing and appetite for this project.

Scoping work for a decision analytic model and cost effectiveness evaluation of newborn screening for SMA. provision of a rapid review of the literature and for a plan to prepare for a future modelling study with clinical and cost effectiveness outco ....

Scoping work for a decision analytic model and cost effectiveness evaluation of new-born screening for Spinal Muscular Atrophy (SMA). Therefore, the service is for the provision of a rapid review of the literature and for a plan to prepare for a futu ....

Scoping work for a decision analytic model and cost effectiveness evaluation of new-born screening for Spinal Muscular Atrophy (SMA). Therefore, the service is for the provision of a rapid review of the literature and for a plan to prepare for a futu ....

The DHSC - UK National Screening Committee is issuing this Prior Information Notice to seek information and feedback from the market to gain better understanding of the intelligence, costing and appetite for this project. We are seeking feedback on t ....

The DHSC - UK National Screening Committee is issuing this Prior Information Notice to seek information and feedback from the market to gain better understanding of the intelligence, costing and appetite for this project. We are seeking feedback on t ....

NHS AGEM CSU on behalf of NHS England Specialised Commissioning is inviting suitably qualified and experienced providers to deliver Treatment to adult patients who have 5Q Spinal Muscular Atrophy (SMA) with the Drug Nusinersen under a compliance proc ....

NHS AGEM CSU on behalf of NHS England Specialised Commissioning is inviting suitably qualified and experienced providers to deliver treatment to adult patients who have 5Q Spinal Muscular Atrophy (SMA) with the drug nusinersen under a compliance proc ....